1. Home
  2. VFC vs CYTK Comparison

VFC vs CYTK Comparison

Compare VFC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V.F. Corporation

VFC

V.F. Corporation

HOLD

Current Price

$19.46

Market Cap

6.8B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.04

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFC
CYTK
Founded
1899
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
VFC
CYTK
Price
$19.46
$63.04
Analyst Decision
Hold
Strong Buy
Analyst Count
16
15
Target Price
$16.13
$77.87
AVG Volume (30 Days)
6.0M
1.8M
Earning Date
01-28-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
$9,541,055,000.00
$87,211,000.00
Revenue This Year
$0.66
$361.33
Revenue Next Year
$0.96
$65.14
P/E Ratio
$84.84
N/A
Revenue Growth
N/A
2609.26
52 Week Low
$9.41
$29.31
52 Week High
$29.02
$69.33

Technical Indicators

Market Signals
Indicator
VFC
CYTK
Relative Strength Index (RSI) 67.78 49.38
Support Level $18.06 $59.56
Resistance Level $20.30 $67.26
Average True Range (ATR) 0.81 2.35
MACD 0.15 -0.66
Stochastic Oscillator 78.63 36.03

Price Performance

Historical Comparison
VFC
CYTK

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: